We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

  • Facebook
  • Twitter
  • Linked In
  • Google+
back top

Professor Henrotin Yves

Henrotin Yves

University of Liège
Department of Physical Activity and Rehabilitation Sciences
Liège, Belgium

Yves Henrotin is Professor of Pathology, Physical Therapy and Rehabilitation and director of the musculoSKeletal Innovative research lab (mSKIL) at the University of Liège (Belgium). He is also Head of the Physical Therapy and Rehabilitation department at the Princess Paola Hospital, Marche-en-Famenne, Belgium. Between 2006 and 2013, he was a member of the board of directors of the Osteoarthritis Research Society International (OARSI). He was elected treasurer in 2010 and chairman of OARSI World Congress. He is also the vice-president of the Spine section and the osteoarthritis section of the French Society of Rheumatology, deputy chair of the Belgium Scientific Society of Physical Therapy since 2008 and deputy chair of the National Council of Physical Therapy and Rehabilitation for the Belgium Health Ministry. He was the Belgium delegate and board member of the COST B13 action “Low back pain: guidelines for its management” organized by European Commission Research Directorate General and is currently the Belgium representative of the COST action NETWOARK. He was the coordinator of the WP 1 of FP-7 programme D-BOARD, a European consortium dedicated to OA biomarkers research. He serves the editorial board of several scientific reviews including Osteoarthritis and Cartilage, the Journal Experimental Orthopaedic and Annals of Physical and Rehabilitation Medicine. He is honorary editor-in-chief of International Journal of Orthopaedics associated editor of Therapeutic Advances in Musculoskeletal diseases.

Prof. Henrotin serves the ICRS since the beginning. Previously, he was member and deputy chair of the publication and communication committee (2019-2022) and member of scientific programme committee (2022-2023). Currently, he is the Chair of the Regulatory and Industry Liaison committee and General Board member. He has published over 250 scientific peer-reviewed papers and 10 chapters of book. He is the co-editor of the book “Osteoarthritis: clinical and experimental aspects” (Springer), co-editor of “Primer in OA” (edited by the OARSI) and editor of the book “Nonpharmacological modalities for the Management of osteoarthritis” (Bentham). In 2005, he received a prestigious national prize (De Cooman Prize) for his contribution in the better understanding of osteoarthritis pathophysiology. He is also the founder and the President of the Osteoarthritis Foundation www.osteoarthritisfoundation.eu.